We’re attending #EANS2026 in Hamburg, one of Europe’s largest neurosurgery congresses, bringing together 2,500+ experts from around the world. Visit us at Booth #23 and join our symposium to explore advances in neuroscience and patient care.
At Servier, nearly 70% of our R&D investment is dedicated to oncology, advancing targeted therapies for cancers including glioma, cholangiocarcinoma and colorectal cancer. 🎗️
🔗 https://f.mtr.cool/45kt0avi9o
#WeAreServier #MovedByYou #Neurosurgery #Neuroscience @EANSonline50